SLC5A2 and type 2 diabetes mellitus: Although there are effects on fluid homeostasis, after 2 years, weight loss resulting from SGLT-2 inhibition in T2DM appears attributable in large part to reduced adipose tissue (measured using dual-energy X-ray absorptiometry) [67].